A new report by the World Health Organization (WHO) warned of the high prevalence of hypertension in the Philippines in 2024, with 33 percent of adults aged 30 to 79 years ...

Researchers conducted a randomized crossover trial with 154 adults living near major highways. Participants used ...

In 2023, there were 437 million disability-adjusted life-years lost from cardiovascular disease, up from 320 million in 1990.

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

Higher blood pressure (BP) at age 7 years is associated with an increased risk for premature cardiovascular disease (CVD) mortality.

When choosing a home blood pressure monitor, the cuff size range is often reported on the cuff itself, on the box, or in the ...

Baxdrostat, an experimental drug, shows promise in lowering blood pressure for individuals with resistant hypertension. Clinical trials reveal significant reductions in systolic blood pressure ...

A scientific statement has been published by the AHA and ACC regarding using risk assessment for BP management for prevention of CVD.

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

The Japanese walking method is gaining attention as a low-impact workout with huge benefits. Learn how the interval walking ...

Only 3.6 million of the 22.8 million adults aged 30–79 years with hypertension in Bangladesh have the condition under control in 2024, according to the latest World Health Organisation (WHO) report.

The new drug Baxdrostat lowers resistant hypertension in difficult-to-treat patients, showing promising results in a global ...